{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T21:39:23Z","timestamp":1794692363575,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T00:00:00Z","timestamp":1339977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"},{"start":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T00:00:00Z","timestamp":1339977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>HIV-1 Tat protein is known to be associated with neuroinflammation, a condition that develops in almost half of patients infected with HIV-1. HIV-1 Tat can alter glial neuroprotective functions, leading to neurotoxicity within the CNS. HIV-1 Tat is known to be secreted from productively infected cells and can affect neighboring uninfected cells by modulating cellular gene expression in a bystander fashion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We were interested to study whether exogenous exposure to HIV-1 Tat-C protein perturbs the microRNA (miRNA) expression profile of human microglial cells, leading to altered protein expression. We used protein expression and purification, miRNA overexpression, miRNA knockdown, transfection, site-directed mutagenesis, real-time PCR, luciferase assay and western blotting techniques to perform our study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>HIV-1 Tat-C treatment of human microglial cells resulted in a dose-dependent increase in miR-32 expression. We found that tumor necrosis factor-receptor\u2013associated factor 3 TRAF3) is a direct target for miR-32, and overexpression of miR-32 in CHME3 cells decreased TRAF3 both at the mRNA and the protein level. Recovery of TRAF3 protein expression after transfection of anti-miR-32 and the results of the luciferase reporter assay provided direct evidence of TRAF3 regulation by miR-32. We found that the regulation of interferon regulatory factor 3 (IRF3) and IRF7 is controlled by cellular levels of TRAF3 protein in microglial cells, as after overexpression of miR-32 and application of anti-miR-32, expression levels of IRF3 and IRF7 were inversely regulated by expression levels of TRAF3. Thus, our results suggest a novel miRNA mediated mechanism for regulation of TRAF3 in human microglial cells exposed to HIV-1 Tat C protein. These results may help to elucidate the detrimental neuroinflammatory consequences of HIV-1 Tat C protein in bystander fashion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>HIV-1 Tat protein can modulate TRAF3 expression through miRNA mediated pathway and can change the downstream expression of IRF3 and IRF7. This study demonstrates a novel mechanism of HIV-1 Tat C protein-mediated perturbation of miRNA, resulting in dysregulation of cellular TRAF3.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-2094-9-131","type":"journal-article","created":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T14:42:51Z","timestamp":1340635371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microglia"],"prefix":"10.1186","volume":"9","author":[{"given":"Ritu","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chintan","family":"Chhatbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunit Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,18]]},"reference":[{"key":"630_CR1_630","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.ajpath.2011.06.039","volume":"179","author":"KA Thompson","year":"2011","unstructured":"Thompson KA, Cherry CL, Bell JE, McLean CA: Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals. \n                           Am J Pathol 2011, 179:1623\u20131629.","journal-title":"Am J Pathol"},{"key":"630_CR2_630","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, et al.: HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. \n                           Neurology 2010, 75:2087\u20132096.","journal-title":"Neurology"},{"key":"630_CR3_630","first-page":"637","volume":"129","author":"D Sharma","year":"2009","unstructured":"Sharma D, Bhattacharya J: Cellular & molecular basis of HIV-associated neuropathogenesis. \n                           Indian J Med Res 2009, 129:637\u2013651.","journal-title":"Indian J Med Res"},{"issue":"Suppl 1","key":"630_CR4_630","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/sj.cdd.4401623","volume":"12","author":"M Kaul","year":"2005","unstructured":"Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA: HIV-1 infection and AIDS: consequences for the central nervous system. \n                           Cell Death Differ 2005,12(Suppl 1):878\u2013892.","journal-title":"Cell Death Differ"},{"key":"630_CR5_630","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1046\/j.1365-2990.1998.00145.x","volume":"24","author":"VJ Sanders","year":"1998","unstructured":"Sanders VJ, Mehta AP, White MG, Achim CL: A murine model of HIV encephalitis: xenotransplantation of HIV-infected human neuroglia into SCID mouse brain. \n                           Neuropathol Appl Neurobiol 1998, 24:461\u2013467.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"630_CR6_630","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/13550280009015824","volume":"6","author":"L Del Valle","year":"2000","unstructured":"Del Valle L, Croul S, Morgello S, Amini S, Rappaport J, Khalili K: Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. \n                           J Neurovirol 2000, 6:221\u2013228.","journal-title":"J Neurovirol"},{"key":"630_CR7_630","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3858\/emm.2009.41.2.011","volume":"41","author":"SM Ju","year":"2009","unstructured":"Ju SM, Song HY, Lee JA, Lee SJ, Choi SY, Park J: Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes. \n                           Exp Mol Med 2009, 41:86\u201393.","journal-title":"Exp Mol Med"},{"key":"630_CR8_630","doi-asserted-by":"publisher","first-page":"e16148","DOI":"10.1371\/journal.pone.0016148","volume":"6","author":"SL Deshmane","year":"2011","unstructured":"Deshmane SL, Mukerjee R, Fan S, Sawaya BE: High-performance capillary electrophoresis for determining HIV-1 Tat protein in neurons. \n                           PLoS One 2011, 6:e16148.","journal-title":"PLoS One"},{"key":"630_CR9_630","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12640-009-9047-8","volume":"16","author":"W Li","year":"2009","unstructured":"Li W, Li G, Steiner J, Nath A: Role of Tat protein in HIV neuropathogenesis. \n                           Neurotox Res 2009, 16:205\u2013220.","journal-title":"Neurotox Res"},{"key":"630_CR10_630","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/13550280802345723","volume":"14","author":"SD Lewis","year":"2008","unstructured":"Lewis SD, Butchi NB, Khaleduzzaman M, Morgan TW, Du M, Pourciau S, Baker DG, Akira S, Peterson KE: Toll-like receptor 7 is not necessary for retroviral neuropathogenesis but does contribute to virus-induced neuroinflammation. \n                           J Neurovirol 2008, 14:492\u2013502.","journal-title":"J Neurovirol"},{"key":"630_CR11_630","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.3390\/ijerph8072980","volume":"8","author":"AD Kraft","year":"2011","unstructured":"Kraft AD, Harry GJ: Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. \n                           Int J Environ Res Public Health 2011, 8:2980\u20133018.","journal-title":"Int J Environ Res Public Health"},{"key":"630_CR12_630","doi-asserted-by":"publisher","first-page":"jc8","DOI":"10.1126\/scisignal.3147jc8","volume":"3","author":"JM Antony","year":"2010","unstructured":"Antony JM: Grooming and growing with microglia. \n                           Sci Signal 2010, 3:jc8.","journal-title":"Sci Signal"},{"key":"630_CR13_630","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jmb.2006.11.011","volume":"366","author":"P Chugh","year":"2007","unstructured":"Chugh P, Fan S, Planelles V, Maggirwar SB, Dewhurst S, Kim B: Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line. \n                           J Mol Biol 2007, 366:67\u201381.","journal-title":"J Mol Biol"},{"key":"630_CR14_630","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/13550280009013158","volume":"6","author":"L Hudson","year":"2000","unstructured":"Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, Male D, Everall I: Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. \n                           J Neurovirol 2000, 6:145\u2013155.","journal-title":"J Neurovirol"},{"key":"630_CR15_630","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2217\/14622416.8.8.971","volume":"8","author":"SK Singh","year":"2007","unstructured":"Singh SK: miRNAs: from neurogeneration to neurodegeneration. \n                           Pharmacogenomics 2007, 8:971\u2013978.","journal-title":"Pharmacogenomics"},{"key":"630_CR16_630","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/hep.24577","volume":"54","author":"JH Fang","year":"2011","unstructured":"Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, Huang X, Zhang JP, Guan XY, Zhuang SM: MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. \n                           Hepatology 2011, 54:1729\u20131740.","journal-title":"Hepatology"},{"key":"630_CR17_630","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature01957","volume":"425","author":"Y Lee","year":"2003","unstructured":"Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN: The nuclear RNase III Drosha initiates microRNA processing. \n                           Nature 2003, 425:415\u2013419.","journal-title":"Nature"},{"key":"630_CR18_630","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nri2708","volume":"10","author":"RM O\u2019Connell","year":"2010","unstructured":"O\u2019Connell RM, Rao DS, Chaudhuri AA, Baltimore D: Physiological and pathological roles for microRNAs in the immune system. \n                           Nat Rev Immunol 2010, 10:111\u2013122.","journal-title":"Nat Rev Immunol"},{"key":"630_CR19_630","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nrn2726","volume":"10","author":"SM Eacker","year":"2009","unstructured":"Eacker SM, Dawson TM, Dawson VL: Understanding microRNAs in neurodegeneration. \n                           Nat Rev Neurosci 2009, 10:837\u2013841.","journal-title":"Nat Rev Neurosci"},{"key":"630_CR20_630","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00702-009-0221-1","volume":"116","author":"HN Shahabi","year":"2009","unstructured":"Shahabi HN, Westberg L, Melke J, Hakansson A, Belin AC, Sydow O, Olson L, Holmberg B, Nissbrandt H: Cytochrome P450 2E1 gene polymorphisms\/haplotypes and Parkinson\u2019s disease in a Swedish population. \n                           J Neural Transm 2009, 116:567\u2013573.","journal-title":"J Neural Transm"},{"key":"630_CR21_630","doi-asserted-by":"publisher","first-page":"41125","DOI":"10.1074\/jbc.M111.268466","volume":"286","author":"JR Chang","year":"2011","unstructured":"Chang JR, Mukerjee R, Bagashev A, Del Valle L, Chabrashvili T, Hawkins BJ, He JJ, Sawaya BE: HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs. \n                           J Biol Chem 2011, 286:41125\u201341134.","journal-title":"J Biol Chem"},{"key":"630_CR22_630","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/978-0-387-70630-6_9","volume":"597","author":"KR Ely","year":"2007","unstructured":"Ely KR, Kodandapani R, Wu S: Protein-protein interactions in TRAF3. \n                           Adv Exp Med Biol 2007, 597:114\u2013121.","journal-title":"Adv Exp Med Biol"},{"key":"630_CR23_630","doi-asserted-by":"publisher","first-page":"36005","DOI":"10.1074\/jbc.M304266200","volume":"278","author":"T Saitoh","year":"2003","unstructured":"Saitoh T, Nakayama M, Nakano H, Yagita H, Yamamoto N, Yamaoka S: TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. \n                           J Biol Chem 2003, 278:36005\u201336012.","journal-title":"J Biol Chem"},{"key":"630_CR24_630","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nri2998","volume":"11","author":"H Hacker","year":"2011","unstructured":"Hacker H, Tseng PH, Karin M: Expanding TRAF function: TRAF3 as a tri-faced immune regulator. \n                           Nat Rev Immunol 2011, 11:457\u2013468.","journal-title":"Nat Rev Immunol"},{"key":"630_CR25_630","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nature04374","volume":"439","author":"G Oganesyan","year":"2006","unstructured":"Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G: Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. \n                           Nature 2006, 439:208\u2013211.","journal-title":"Nature"},{"key":"630_CR26_630","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2010.08.014","volume":"33","author":"R Perez de Diego","year":"2010","unstructured":"Perez de Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, Picard C, Herman M, Cardon A, Durandy A, Bustamante J, et al.: Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. \n                           Immunity 2010, 33:400\u2013411.","journal-title":"Immunity"},{"key":"630_CR27_630","doi-asserted-by":"publisher","first-page":"12971","DOI":"10.1074\/jbc.M109.076091","volume":"285","author":"P Bista","year":"2010","unstructured":"Bista P, Zeng W, Ryan S, Bailly V, Browning JL, Lukashev ME: TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor. \n                           J Biol Chem 2010, 285:12971\u201312978.","journal-title":"J Biol Chem"},{"key":"630_CR28_630","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1073\/pnas.0707959105","volume":"105","author":"B Zarnegar","year":"2008","unstructured":"Zarnegar B, Yamazaki S, He JQ, Cheng G: Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. \n                           Proc Natl Acad Sci U S A 2008, 105:3503\u20133508.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"630_CR29_630","doi-asserted-by":"publisher","first-page":"9470","DOI":"10.1074\/jbc.M109.071043","volume":"285","author":"AP Mao","year":"2010","unstructured":"Mao AP, Li S, Zhong B, Li Y, Yan J, Li Q, Teng C, Shu HB: Virus-triggered ubiquitination of TRAF3\/6 by cIAP1\/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. \n                           J Biol Chem 2010, 285:9470\u20139476.","journal-title":"J Biol Chem"},{"key":"630_CR30_630","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.016303-0","volume":"91","author":"B Romani","year":"2010","unstructured":"Romani B, Engelbrecht S, Glashoff RH: Functions of Tat: the versatile protein of human immunodeficiency virus type 1. \n                           J Gen Virol 2010, 91:1\u201312.","journal-title":"J Gen Virol"},{"key":"630_CR31_630","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.bbagrm.2011.06.012","volume":"1809","author":"IW Boss","year":"2011","unstructured":"Boss IW, Renne R: Viral miRNAs and immune evasion. \n                           Biochim Biophys Acta 2011, 1809:708\u2013714.","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl","key":"630_CR32_630","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1038\/ng1803","volume":"38","author":"E Hornstein","year":"2006","unstructured":"Hornstein E, Shomron N: Canalization of development by microRNAs. \n                           Nat Genet 2006,38(Suppl):S20-S24.","journal-title":"Nat Genet"},{"key":"630_CR33_630","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1101\/gad.1519207","volume":"21","author":"X Cao","year":"2007","unstructured":"Cao X, Pfaff SL, Gage FH: A functional study of miR-124 in the developing neural tube. \n                           Genes Dev 2007, 21:531\u2013536.","journal-title":"Genes Dev"},{"key":"630_CR34_630","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/jcp.21452","volume":"216","author":"D Eletto","year":"2008","unstructured":"Eletto D, Russo G, Passiatore G, Del Valle L, Giordano A, Khalili K, Gualco E, Peruzzi F: Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a. \n                           J Cell Physiol 2008, 216:764\u2013770.","journal-title":"J Cell Physiol"},{"key":"630_CR35_630","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","volume":"55","author":"AD Frankel","year":"1988","unstructured":"Frankel AD, Pabo CO: Cellular uptake of the tat protein from human immunodeficiency virus. \n                           Cell 1988, 55:1189\u20131193.","journal-title":"Cell"},{"key":"630_CR36_630","doi-asserted-by":"publisher","first-page":"12292","DOI":"10.1074\/jbc.M110.203083","volume":"286","author":"F Cardarelli","year":"2011","unstructured":"Cardarelli F, Serresi M, Albanese A, Bizzarri R, Beltram F: Quantitative analysis of Tat peptide binding to import carriers reveals unconventional nuclear transport properties. \n                           J Biol Chem 2011, 286:12292\u201312299.","journal-title":"J Biol Chem"},{"key":"630_CR37_630","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/emboj.2009.10","volume":"28","author":"R Fiore","year":"2009","unstructured":"Fiore R, Khudayberdiev S, Christensen M, Siegel G, Flavell SW, Kim TK, Greenberg ME, Schratt G: Mef2-mediated transcription of the miR379\u2013410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels. \n                           EMBO J 2009, 28:697\u2013710.","journal-title":"EMBO J"},{"key":"630_CR38_630","doi-asserted-by":"publisher","first-page":"e1000650","DOI":"10.1371\/journal.ppat.1000650","volume":"5","author":"P Nakhaei","year":"2009","unstructured":"Nakhaei P, Mesplede T, Solis M, Sun Q, Zhao T, Yang L, Chuang TH, Ware CF, Lin R, Hiscott J: The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I\/MAVS signaling pathway by targeting TRAF3 for degradation. \n                           PLoS Pathog 2009, 5:e1000650.","journal-title":"PLoS Pathog"},{"key":"630_CR39_630","doi-asserted-by":"publisher","first-page":"8328","DOI":"10.1128\/JVI.00570-11","volume":"85","author":"L Wang","year":"2011","unstructured":"Wang L, Toomey NL, Diaz LA, Walker G, Ramos JC, Barber GN, Ning S: Oncogenic IRFs Provide a Survival Advantage for Epstein-Barr Virus- or Human T-Cell Leukemia Virus Type 1-Transformed Cells through Induction of BIC Expression. \n                           J Virol 2011, 85:8328\u20138337.","journal-title":"J Virol"},{"key":"630_CR40_630","doi-asserted-by":"publisher","first-page":"30099","DOI":"10.1074\/jbc.M401428200","volume":"279","author":"G Xiao","year":"2004","unstructured":"Xiao G, Fong A, Sun SC: Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. \n                           J Biol Chem 2004, 279:30099\u201330105.","journal-title":"J Biol Chem"},{"key":"630_CR41_630","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1097-2765(01)00187-3","volume":"7","author":"G Xiao","year":"2001","unstructured":"Xiao G, Harhaj EW, Sun SC: NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. \n                           Mol Cell 2001, 7:401\u2013409.","journal-title":"Mol Cell"},{"key":"630_CR42_630","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-065X.2011.01055.x","volume":"244","author":"JM Hildebrand","year":"2011","unstructured":"Hildebrand JM, Yi Z, Buchta CM, Poovassery J, Stunz LL, Bishop GA: Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions. \n                           Immunol Rev 2011, 244:55\u201374.","journal-title":"Immunol Rev"},{"key":"630_CR43_630","doi-asserted-by":"publisher","first-page":"e9172","DOI":"10.1371\/journal.pone.0009172","volume":"5","author":"ED Tang","year":"2010","unstructured":"Tang ED, Wang CY: TRAF5 is a downstream target of MAVS in antiviral innate immune signaling. \n                           PLoS One 2010, 5:e9172.","journal-title":"PLoS One"},{"key":"630_CR44_630","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ni.1819","volume":"11","author":"PH Tseng","year":"2010","unstructured":"Tseng PH, Matsuzawa A, Zhang W, Mino T, Vignali DA, Karin M: Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. \n                           Nat Immunol 2010, 11:70\u201375.","journal-title":"Nat Immunol"},{"key":"630_CR45_630","doi-asserted-by":"publisher","first-page":"55855","DOI":"10.1074\/jbc.M407284200","volume":"279","author":"L He","year":"2004","unstructured":"He L, Grammer AC, Wu X, Lipsky PE: TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation. \n                           J Biol Chem 2004, 279:55855\u201355865.","journal-title":"J Biol Chem"},{"key":"630_CR46_630","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1126\/science.1157340","volume":"321","author":"A Matsuzawa","year":"2008","unstructured":"Matsuzawa A, Tseng PH, Vallabhapurapu S, Luo JL, Zhang W, Wang H, Vignali DA, Gallagher E, Karin M: Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. \n                           Science 2008, 321:663\u2013668.","journal-title":"Science"},{"key":"630_CR47_630","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.4049\/jimmunol.1100642","volume":"187","author":"F Sun","year":"2011","unstructured":"Sun F, Zhang YB, Liu TK, Shi J, Wang B, Gui JF: Fish MITA serves as a mediator for distinct fish IFN gene activation dependent on IRF3 or IRF7. \n                           J Immunol 2011, 187:2531\u20132539.","journal-title":"J Immunol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-9-131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1742-2094-9-131\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-9-131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-9-131.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:23:49Z","timestamp":1630524229000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-9-131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,18]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["630"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-9-131","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,18]]},"assertion":[{"value":"3 February 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"131"}}